(Q31966048)

English

Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) i

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) i (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

based on heuristic

inferred from title

author name string

P H Dunselman

1

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Replacement of Angiotensin Converting Enzyme Inhibition (REPLACE) Investigators

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

publication date

1 February 2001

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

International Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

77

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

2-3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

131-8; discussion 139-40

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of heart failure in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin receptors and their antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel drugs and current therapeutic approaches in the treatment of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2800%2900426-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0167-5273(00)00426-5

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31966048&oldid=2067454019"